ProPhase Labs, Inc. — Director's Dealing 2024

Mar 21, 2024

SEC Form 4/A — Form 4/A

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2024-03-17

Reporting Person: Karkus Ted William (Director, CEO & CHAIRMAN, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-17	Option (right to buy)	$6.00	A	400000	Acquired	2031-03-17	Common Stock (400000)	Direct

Footnotes

F1: Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on the grant date and the remainder vesting and becoming exercisable in equal annual installments on the first, second and third anniversaries of the grant date.

F2: This amended report on Form 4 is being filed to correct the information in Table II, Box 5 as the share amount was inadvertently reported under the wrong subheading in the original Form 4 filed on March 19, 2024.